These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39101178)
1. Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection. Murakawa K; Aasi H; Sato K; Yoshioka S; Sho H; Inui R; Kosugi M; Hazama Y; Yasuda T Diabetol Int; 2024 Jul; 15(3):621-626. PubMed ID: 39101178 [TBL] [Abstract][Full Text] [Related]
2. Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic. Sano H; Imagawa A Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36421377 [TBL] [Abstract][Full Text] [Related]
3. Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies. Mishra R; Elshimy G; Kannan L; Jacob A; Raj R Front Endocrinol (Lausanne); 2022; 13():983206. PubMed ID: 36034456 [TBL] [Abstract][Full Text] [Related]
4. Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy. Zhou L; Qu H; Zhang Q; Hu J; Shou L Front Endocrinol (Lausanne); 2023; 14():1168927. PubMed ID: 37082120 [TBL] [Abstract][Full Text] [Related]
5. The fulminant index: A method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis. Qiu J; Li X; Chen W; Ma X; Xie Z; Huang G; Luo S; Zhou Z Diabetes Metab Res Rev; 2022 Mar; 38(3):e3501. PubMed ID: 34614535 [TBL] [Abstract][Full Text] [Related]
6. New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review. Huang L; Liang M; He Y J Korean Med Sci; 2023 Jun; 38(24):e209. PubMed ID: 37337812 [TBL] [Abstract][Full Text] [Related]
7. A case report of fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome in an elderly patient with coxsackie B4 virus infection and human leukocyte antigen-A24 haplotype. Takeno A; Kanazawa I; Morita M; Takedani K; Miyake H; Yamamoto M; Nogami K; Kaneko S; Sugimoto T Endocr J; 2018 Jan; 65(1):129-132. PubMed ID: 28966225 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study. Boboc AA; Novac CN; Marin AG; Ieșanu MI; Plătică C; Buzescu T; Coșoreanu MT; Galoș F Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240231 [TBL] [Abstract][Full Text] [Related]
9. New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report. Sasaki K; Morioka T; Okada N; Natsuki Y; Kakutani Y; Ochi A; Yamazaki Y; Shoji T; Ohmura T; Emoto M J Diabetes Investig; 2022 Jul; 13(7):1286-1289. PubMed ID: 35167186 [TBL] [Abstract][Full Text] [Related]
10. Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report. Lin R; Lin YW; Chen MH Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423001 [TBL] [Abstract][Full Text] [Related]
11. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral. Kusuki K; Suzuki S; Mizuno Y Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673 [TBL] [Abstract][Full Text] [Related]
12. Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes. Haseda F; Imagawa A; Nishikawa H; Mitsui S; Tsutsumi C; Fujisawa R; Sano H; Murase-Mishiba Y; Terasaki J; Sakaguchi S; Hanafusa T PLoS One; 2016; 11(8):e0160576. PubMed ID: 27513516 [TBL] [Abstract][Full Text] [Related]
13. Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination. Izumi T; Takahashi H; Takahashi H Diabetol Int; 2023 Oct; 14(4):422-426. PubMed ID: 37781472 [TBL] [Abstract][Full Text] [Related]
14. Recent findings on fulminant type 1 diabetes. Liu L; Zeng L; Sang D; Lu Z; Shen J Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28817230 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Unmasks Type 1 Diabetes Mellitus With an Episode of Diabetic Ketoacidosis. Halioti A; Kitinou M; Chalioti VM; Chaliotis G J Med Cases; 2022 Sep; 13(9):432-437. PubMed ID: 36258706 [TBL] [Abstract][Full Text] [Related]
16. Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report. Iwata Y; Matsuhashi N; Takahashi T; Suetsugu T; Fukada M; Yasufuku I; Imai T; Tanahashi T; Matsui S; Imai H; Tanaka Y; Yamaguchi K; Yoshida K Mol Clin Oncol; 2019 Aug; 11(2):189-191. PubMed ID: 31281655 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognosis of fulminant type 1 diabetes mellitus in The Middle East: a comparative analysis in a 5-year nationwide cohort. Ata F; Khan AA; Khamees I; AlKodmani S; Al-Sadi A; Yaseen KB; Muthanna B; Godwin A; Beer SF; Bashir M BMC Endocr Disord; 2024 Mar; 24(1):33. PubMed ID: 38462602 [TBL] [Abstract][Full Text] [Related]
18. Fulminant Type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome. Kim HS; Lee TY; Kim EY; Choi JH; Kim SY; Hwang YC; Kang JH; Ahn KJ; Chung HY; Jeong IK Diabet Med; 2012 Oct; 29(10):1335-8. PubMed ID: 22356444 [TBL] [Abstract][Full Text] [Related]
19. Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab. Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z Tohoku J Exp Med; 2018 Jan; 244(1):33-40. PubMed ID: 29343652 [TBL] [Abstract][Full Text] [Related]
20. Fulminant Type 1 Diabetes Mellitus Associated with Coxsackie Virus Type A2 Infection: A Case Report and Literature Review. Ohara N; Kaneko M; Nishibori T; Sato K; Furukawa T; Koike T; Sone H; Kaneko K; Kamoi K Intern Med; 2016; 55(6):643-6. PubMed ID: 26984083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]